Publications by authors named "Samuel J Harris"

Claim this Profile
N
Nivolumab and Ipilimumab in Advanced Mismatch Repair-Deficient/Microsatellite Instability-High Noncolorectal Cancers: A Nonrandomized Clinical Trial.
Matteo S Carlino, Bo Gao, Michael Michael, Henry Marshall, Ashray Gunjur, Samuel J Harris

JAMA Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vortex equilibria using least-squares methods.
Samuel J Harris, N R McDonald

Theor Comput Fluid Dyn· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial.
Jeanne Tie, Yuxuan Wang, Serigne N Lo, Kamel Lahouel, Joshua D Cohen, Samuel J Harris, Marion Harris

Nat Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in cancer clinical trial activity and trial characteristics at metropolitan and rural trial sites in Victoria, Australia.
Narelle J McPhee, Michael Leach, Claire E Nightingale, Samuel J Harris, Eva Segelov

Aust J Rural Health· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Controlling Excited State Localization in Bichromophoric Photosensitizers via the Bridging Group.
Georgina E Shillito, Dan Preston, James D Crowley, Pawel Wagner, Samuel J Harris

Inorg Chem· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Tuning of Electronic Ground and Excited States in Donor-Acceptor Dyes; Steps toward Designer Compounds for Modern Technologies.
Samuel J Harris, C John McAdam, Pawel Wagner, Joseph I Mapley, Keith C Gordon

J Phys Chem A· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of the Geometric and Spectroscopic Properties of Four Twisted Triphenylpyridinium Donor-Acceptor Dyes.
Samuel J Harris, Christopher Richardson, Joseph I Mapley, Pawel Wagner, Keith C Gordon

J Phys Chem A· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers and enablers to cancer clinical trial participation and initiatives to improve opportunities for rural cancer patients: A scoping review.
Narelle J McPhee, Claire E Nightingale, Samuel J Harris, Eva Segelov, Eli Ristevski

Clin Trials· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermittent schedules of the oral RAF-MEK inhibitor CH5126766/VS-6766 in patients with RAS/RAF-mutant solid tumours and multiple myeloma: a single-centre, open-label, phase 1 dose-escalation and basket dose-expansion study.
Christina Guo, Maxime Chénard-Poirier, Desamparados Roda, Maria de Miguel, Samuel J Harris

Lancet Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radium-223 in combination with paclitaxel in cancer patients with bone metastases: safety results from an open-label, multicenter phase Ib study.
Ravit Geva, Juanita Lopez, Sarah Danson, Heikki Joensuu, Avivit Peer, Samuel J Harris

Eur J Nucl Med Mol Imaging· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target-based therapeutic matching of phase I trials in patients with metastatic breast cancer in a tertiary referral centre.
Brent O'Carrigan, Joline Si Jing Lim, Awais Jalil, Samuel John Harris, Dionysis Papadatos-Pastos

Br J Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immuno-oncology combinations: raising the tail of the survival curve.
Samuel J Harris, Jessica Brown, Juanita Lopez, Timothy A Yap

Cancer Biol Med· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and advancing systemic treatment options for soft tissue sarcomas.
Samuel J Harris, Charlotte Benson, Robin L Jones

Expert Opin Pharmacother· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory breast cancer and secondary Pure Red Cell Aplasia.
Samuel J Harris, Jo-An A Seah, Frances Barnett, Shane C White

Acta Oncol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis